Work

5-HT2C Agonists as Therapeutics for the Treatment of Schizophrenia

Year: 2012

Type: book-chapter

Source: Handbook of experimental pharmacology

DOI: 10.1007/978-3-642-25758-2_6

Authors: Sharon Rosenzweig-Lipson, Thomas A. Comery, Karen L. Marquis, Jonathan Gross, John Dunlop

Institutions: Pfizer (United States), AstraZeneca (United Kingdom)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1761374501

FWCI: 19.03

Cites: 85

Cited by: 42

Related to: 10